UBS analyst Faham Baig maintains Philip Morris Intl (NYSE:PM) with a Neutral and raises the price

FDA authorizes Philip Morris' unit to market 20 ZYN nicotine pouches with reduced disease risk c

The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced tha

Altria maintains a dominant position in the U.S. tobacco market with industry-leading net margins an

The U.S. Food and Drug Administration proposed a rule on Friday that would require foreign tobacco p

Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute's i

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) has been named in t

In times of market turbulence, investors turn to high-dividend stocks. Benzinga offers accurate anal

https://en.agcm.it/en/media/press-releases/2026/6/PS12940-

Morgan Stanley analyst Eric Serotta maintains Philip Morris Intl (NYSE:PM) with a Overweight and

Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, will address inv

Consumer staples stocks flashing warning to momentum traders. RSI above 70 signals overbought assets

https://www.wsj.com/politics/policy/trump-pressures-fda-commissioner-to-approve-flavored-vapes-9dad8

Needham analyst Gerald Pascarelli reiterates Philip Morris Intl (NYSE:PM) with a Buy and maintain

Tech stocks brushed new record highs during midday Wednesday, as a fresh wave of blockbuster corpora

Philip Morris stock jumps after a strong earnings beat driven by smoke-free growth, despite trimming

Philip Morris Intl (NYSE:PM) lowers FY2026 GAAP EPS guidance from $7.87-$8.02 to $7.56-$7.71 vs $7.9

Philip Morris Intl (NYSE:PM) lowers FY2026 Adj EPS guidance from $8.38-$8.53 to $8.36-$8.51 vs $8.40

Philip Morris Intl (NYSE:PM) reported quarterly earnings of $1.96 per share which beat the analyst c

The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified

UBS analyst Faham Baig maintains Philip Morris Intl (NYSE:PM) with a Neutral and lowers the price

Morgan Stanley analyst Eric Serotta maintains Philip Morris Intl (NYSE:PM) with a Overweight and

Needham analyst Gerald Pascarelli maintains Philip Morris Intl (NYSE:PM) with a Buy and lowers th

Trump, in January, said "inflation has been defeated." Wall Street is now bracing for a 0.9%

Philip Morris International shares are trading lower Wednesday morning after Reuters reported that t

https://www.reuters.com/business/healthcare-pharmaceuticals/worries-over-science-new-addicts-stymie-

New business hub will advance U.S. operations and support company's mission to deliver a smoke-f

India's steadfastness in maintaining its ban on e-cigarettes, including heat-not-burn tobacco pr

Philip Morris' India cigarettes market share has grown over timeIndia banned e-cigarettes, heate

Needham analyst Gerald Pascarelli maintains Philip Morris Intl (NYSE:PM) with a Buy and raises th

Philip Morris International reported strong smoke-free momentum and record Marlboro share with upbea

Philip Morris Intl (NYSE:PM) reported quarterly earnings of $1.70 per share which met the analyst co

U.S. stocks declined, with Dow Jones falling almost 600 points and software stocks dipping for an ei

U.S. stock futures down; AutoNation, Amazon, Philip Morris, Reddit, and Biogen expected to report qu

Philip Morris (NYSE: PM) to release Q4 earnings on Feb. 6. Analysts expect $1.70/share. Dividend yie

Here's a look at this week's earnings calendar, featuring over 100 S&P 500 members.

Philip Morris asked the FDA to allow reduced-risk claims for ZYN, citing advisory-panel-reviewed evi

In January 2025, ZYN became the first nicotine pouch product authorized for marketing by the FDAExpe

Jefferies analyst Edward Mundy downgrades Philip Morris Intl (NYSE:PM) from Buy to Hold and lower